BridgeBio Pharma, Inc.

NASDAQ:BBIO

47.37 (USD) • At close August 1, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 116.6335.8822.7322.168211.121.7454.0911.6411.8261.870.33873.7461.69412.8862.34454.0240.4620.1228.1270013.81926.741000000
Kosten van de omzet 0.6052.0840.5980.5981.8940.5980.5980.5990.6510.6470.7390.71.3481.5511.4540.1090000002.5000000
Brutowinst 116.0283.7982.1341.57209.2261.1473.4931.0421.1751.223-0.40173.0460.34611.3350.8953.9150.4620.1228.1270013.81924.241000000
Brutowinstmarge 0.9950.6460.7810.7240.9910.6570.8540.6350.6430.654-1.1860.9910.2040.880.380.9981110010.907000000
Onderzoek- en ontwikkelingskosten 111.431130.35120.444114.695140.972130.226125.136108.08793.51291.54992.511108.4107.649123.751104.305102.069122.55990.17492.0586.59868.22557.48555.27852.33144.85351.20231.14823.89233.831
Algemene en administratieve kosten 000000000000045.4070045.40737.43736.01637.96934.26234.97223.49516.91818.89914.38110.30810.8918.007
Verkoop- en marketingkosten 00000000000009.342000000000000000
Verkoop-, algemene en administratieve kosten 106.36594.78268.81959.52364.51147.58335.77736.12231.10831.86231.18836.42643.71354.74946.08445.9745.40737.43736.01637.96934.26234.97223.49516.91818.89914.38110.30810.8918.007
Overige kosten 2.6044.6934.6212.891000.2720-0.60100000-0.6840000.00900.474-0.158-0.026-0.007-0.0070.0050.00600
Bedrijfskosten 220.4229.825193.884177.109205.483177.809161.185144.209124.62123.411123.699144.826151.362178.5150.389148.039167.966127.611128.066124.567102.48792.45778.77369.24963.75265.58341.45634.78341.838
Bedrijfsresultaat -104.372-226.027-191.75-175.5393.743-177.416-157.692-146.099-126.163-122.188-129.11626.116-151.016-165.614-149.499-94.015-167.504-127.489-119.939-124.567-102.487-78.638-54.532-69.249-63.752-65.583-41.456-34.783-41.838
Bedrijfsresultaat ratio -0.895-38.427-70.187-80.9680.018-101.671-38.546-89.03-69.093-65.341-3820.354-89.148-12.852-63.779-1.74-362.563-1,044.992-14.75800-5.691-2.039000000
Totaal overige inkomsten en kosten netto -63.05-40.20927.49699.995-36.5037.088-21.796-14.604-16.569-11.338-11.07777.617-27.65213.332-11.517-8.059-3.578-7.536-10.228-11.647-1.595-5.513-6.132-5.016-5.68416.342-0.622-0.919-0.592
Inkomen voor belasting -167.422-266.236-164.254-75.544-36.16-170.328-176.999-160.703-142.732-140.57-140.193-2.559-201.33-152.282-161.016-102.074-171.082-135.025-130.167-136.214-104.082-84.151-60.664-74.265-69.436-49.241-42.078-35.702-42.43
Inkomen voor belasting ratio -1.435-45.263-60.122-34.845-0.171-97.609-43.265-97.93-78.166-75.171-414.772-0.035-118.849-11.818-68.693-1.889-370.307-1,106.762-16.01700-6.09-2.269000000
Belastingkosten 2.1861.15300-0.9440-1.639034.11415.4038.223-61.92445.3810000000000-11.39200000
Nettowinst -167.422-265.05-162.04-73.456-35.216-168.148-176.999-157.899-176.846-155.973-148.41659.365-246.711-147.177-155.935-96.348-163.079-119.981-115.859-121.034-91.85-73.458-59.98-65.895-61.185-38.641-31.401-26.551-34.156
Nettowinstmarge -1.435-45.061-59.312-33.882-0.167-96.36-43.265-96.221-96.849-83.408-439.1010.805-145.638-11.421-66.525-1.783-352.985-983.451-14.25600-5.316-2.243000000
WPA (Winst Per Aandeel) -0.88-1.4-0.86-0.39-0.2-0.96-1.08-0.98-1.16-1.04-10.4-1.69-1.01-1.06-0.66-1.18-1.01-0.98-1.03-0.78-0.62-0.51-0.71-0.51-0.42-0.34-0.29-0.37
Verwaterde WPA -0.88-1.4-0.86-0.39-0.2-0.96-1.08-0.98-1.16-1.04-10.4-1.69-1.01-1.06-0.66-1.18-1.01-0.98-1.03-0.78-0.62-0.51-0.71-0.51-0.42-0.34-0.29-0.37
EBITDA -126.183-235.048-139.655-51.033-11.093-148.475-157.543-138.472-120.978-118.92-118.723-70.198-179.102-137.173-149.684-88.548-159.979-124.415-119.238-124.567-100.072-81.111-58.177-72.192-67.653-64.28-40.845-35.455-42.397
EBITDA ratio -1.082-39.961-51.118-23.539-0.053-85.086-38.51-84.383-66.253-63.594-351.251-0.952-105.727-10.645-63.858-1.639-346.275-1,019.795-14.67200-5.87-2.176000000